© Provided by Xinhua We have achieved exemplary large-scale epidemiological laboratory work to demonstrate how the effectiveness of the vaccine can sav
The prestigious Butantan Institute Monday released the results of a study carried out between February and April 2021 among 27,000 people vaccinated with CoronaVac in Serrana, São Paulo, which showed a 95% decrease in deaths from covid-19, it was announced.
01 Jun 2021 (Last Updated June 1st, 2021 11:31)
Data from Brazil s mass Covid-19 trial showed that symptomatic cases reduced by 80% and hospitalisations dropped by 86%.
Share Article
Brazil has recorded a 95% reduction in deaths in the first-ever mass Covid-19 trial, during which an entire town in the country was inoculated with China-based Sinovac Biotech’s CoronaVac vaccine.
Named Project S, the trial ran between February and April, vaccinating all adults in the Serrana town, which has a total population of 45,000 people.
Approximately 75% of residents were completely vaccinated and of the target adult population, 95% turned up for both doses, Bloomberg noted.
About one-third of the town’s population was ineligible for the vaccine due to being under 18 years old or pregnant.
A Sinovac vaccine trial has helped a Brazilian city lower COVID-19 deaths by 95%. Hospitalizations and symptomatic cases have also gone down by 86% and 80%, respectively, while only one COVID-19